• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Attn: HCV People - Only 2 "nucs" left

Anonymous

Guest
Sofosbuvir & IDX21437 (in the whole wide world) . Well, yes- I guess there is ours (vertex's) . If you think a crippled, leased, wounded, on-hold, toxic POS is considered a NUC. HEY! Don't miss the point! 2 Nucs left....one at a 108 billion dollar company (even it has a patent infringement lawsuit against it by Idenix) & one at Idenix.

Oh, by the way.... thanks for screwing it up for us soooo bad by buying a 2.5 Billion dollar Phenol laden POS that wasn't even tested more than 7 days in humans,,,,,,, but who cares... it just let me and a lot more people and hedge funds buy the stock at absurdly low prices.